Dr. Reddy's Laboratories Ltd receives EIR from USFDA for Vizag unit

Dr. Reddy's Laboratories Ltd had earlier announced about the audit conducted by the USFDA at its formulations manufacturing facilities (FTO 7 & FTO 9) at Duvvada, Visakhapatnam. The Company has received the Establishment Inspection Report (EIR) from the USFDA indicating closure of the inspection.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4321.00 as compared to the previous close of Rs. 4301.55. The total number of shares traded during the day was 8998 in over 1808 trades.

The stock hit an intraday high of Rs. 4343.90 and intraday low of 4266.00. The net turnover during the day was Rs. 38784884.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 Pharmaceuticals RDY EIR USFDA Duvvada Visakhapatnam FormulationsFacility